Promontory Therapeutics Inc.
3 clinical trials · Sponsor
◉ Watch Promontory Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab (NCT03409458) | Promontory Therapeutics Inc. | 2018-04-24 |
| A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma (NCT03288480) | Promontory Therapeutics Inc. | 2017-12-15 |
Track Promontory Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.